SciHub
文献互助
期刊查询
一搜即达
科研导航
交流社区
登录
注册
发布
文献
求助
首页
我的求助
捐赠本站
老刘Diamond
Lv4
1
640 积分
2023-06-19 加入
最近求助
最近应助
互助留言
The Drug-Dosing Conundrum in Oncology — When Less Is More
3天前
已完结
Improving Dose-Optimization Processes Used in Oncology Drug Development to Minimize Toxicity and Maximize Benefit to Patients
3天前
已完结
Tislelizumab plus chemotherapy versus placebo plus chemotherapy as first line treatment for advanced gastric or gastro-oesophageal junction adenocarcinoma: RATIONALE-305 randomised, double blind, phase 3 trial
15天前
已完结
Recent developments in perioperative combination therapy in muscle-invasive bladder cancer
1个月前
已完结
Perioperative Immunotherapy in Muscle-Invasive Bladder Cancer
1个月前
已完结
Recent developments in perioperative combination therapy in muscle-invasive bladder cancer
1个月前
已完结
Perioperative Immunotherapy in Muscle-Invasive Bladder Cancer
1个月前
已完结
Improving immunotherapy outcomes with anti-angiogenic treatments and vice versa
1个月前
已完结
Tepotinib plus osimertinib in patients with EGFR-mutated non-small-cell lung cancer with MET amplification following progression on first-line osimertinib (INSIGHT 2): a multicentre, open-label, phase 2 trial
1个月前
已完结
MET alterations in advanced non-small cell lung cancer
1个月前
已完结
没有进行任何应助
纯摘要【积分已退回】
7个月前
未下载到【积分已退回】
1年前
感谢
1年前
最近帖子
最近评论
没有发布任何帖子
没有发布任何评论